[1] This CPG is intended to provide healthcare providers with a framework by which to evaluate, treat, and manage the individual needs and preferences of patients with hypertension (HTN), thereby leading to improved clinical outcomes. In 2014, the VA and DoD published a CPG for the Diagnosis and Management of Hypertension in the Primary Care Setting (2014 VA/DoD HTN CPG), which was based on evidence reviewed through April 2014. Since the release of that guideline, a growing body of research has expanded the general knowledge and understanding of HTN. Consequently, a recommendation to update the 2020 VA/DoD HTN CPG was initiated in 2018. The updated 2020 VA/DoD HTN CPG includes objective, evidence-based information on the diagnosis and management of HTN. It is intended to assist healthcare providers in all aspects of patient care, including, but not limited to, screening, diagnosis, and management. The system-wide goal of evidence-based guidelines is to improve the patient s health and well-being by guiding health providers who are caring for patients with HTN along management pathways that are supported by the evidence. The expected outcome of successful implementation of this guideline is to: Assess the individual s condition and determine the best treatment method, in collaboration with the patient Optimize health outcomes and improve quality of life Minimize preventable complications and morbidity Emphasize the use of patient-centered care (PCC) II. Background This guideline, developed under the auspices of the VHA and the DoD pursuant to directives from the VA, is an update to the 2014 VA/DoD Clinical Practice Guideline for Diagnosis and Management of Hypertension in the Primary Care Setting. The definition of HTN continues to evolve and an international consensus does not exist. 